Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Eylea set to challenge Lucentis in UK after NICE recommendation

Eylea set to challenge Lucentis in UK after NICE recommendation Novartis has seen its drug Lucentis (ranibizumab) become the standard-of-care in the country for wet AMD – the most common cause of blindness in the western world – after it was ... However, Eylea (aflibercept) today received final draft guidance

Novartis wins third NICE recommendation for Lucentis

Novartis wins third NICE recommendation for Lucentis This adds to a recommendation in February 2013 for the use of Lucentis to treat diabetes-related macular oedema and a 2008 recommendation to treat age-related macular degeneration. ... However, as with Lucentis' previous NICE recommendations, Novartis

NICE turns down Novartis’ blood cancer drug Jakavi

NICE turns down Novartis’ blood cancer drug Jakavi for several other products,  including Gilenya, Tasigna and Lucentis, that were subsequently given the green light.

Boehringer backs gene therapy firm Eyevensys

Boehringer backs gene therapy firm Eyevensys At the moment, the treatment for AMD relies on regular intraocular injections of drugs such as Novartis' Lucentis (ranibizumab) and Bayer's Eylea (aflibercept).

Additional NICE recommendation for Novartis’ Lucentis

Additional NICE recommendation for Novartis’ Lucentis Novartis has received an additional draft recommendation in macular oedema from the UK's National Institute for Health and Care Excellence (NICE) for Lucentis. ... NICE's final decision on the use of Lucentis visual impairment due to macular oedema

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics